Christmas is here: our first 3 contracts signed in Q4 2020 !

2020… What a year ! Happy to start 2021 in the best conditions possible, announcing that TreeFrog Therapeutics signed 3 contracts in Q4 2020:We announced in November a partnership with the French Blood Agency (EFS) for the mass-production of iPS-derived HSC transplants2 additional contracts with undisclosed...